Non Tuberculous Mycobacteria Infection Market

1
(No Transcript)
2
Non Tuberculous Mycobacteria Infection (NTMI)
01
02
03
04

• DelveInsight 2019 All rights reserved

3
NTMI Epidemiology
CASES
More than 80,000 NTMI cases were observed in
Japan in 2017.
Prevalence
Approximately 366,800 NTMI prevalent cases were
observed in the United States in 2017.
INFECTED
More than 180,000 cases of NTM (Infected) were
observed in the United States in 2017.
PREVALENCE
Approximately 10,200 NTMI infected prevalent
cases were observed in France in 2017.

• DelveInsight 2019 All rights reserved

4
NTMI Market
NTMI therapeutic market is dependent on the use
of antibiotics either as a monotherapy of in
combination based on the severity level of the
infections.
There are a large number of clinical trials
evaluating potential treatments. Hence,
increasing RD activities, and positive results
of these trials shall fuel NTMI therapeutic
market size.
NTMI is relatively resistant to antibiotics and
can become more resistant if only one antibiotic
is used to treat NTMI.
01
02
03
04
05
Azithromycin, Ciprofloxacin, minocycline are the
commonly prescribed oral antibiotics for this
infection, Cefoxitin and Imipenem are for
intravenous antibiotics whereas Cefoxitin and
Imipenem are the mostly used inhaled antibiotics.
Ongoing trials on the use Nitric acid may bring a
significant change in NTMI treatment algorithm.
NTMI market size is expected to increase at a
significant growth during the study period
2017-2028

• DelveInsight 2019 All rights reserved

5
NTMI Emerging Drugs and Companies
NTMI market dynamics is anticipated to change in
the coming years owing to the improvement in the
diagnosis methodologies, raising awareness of the
disease, and expected the launch of NTMI emerging
therapies during the forecasted period of
2019-2028.
Drug RHB-204 By Redhill Biopharma
Drug Molgramostim By Savara Pharma

• DelveInsight 2019 All rights reserved

6
Complete Information
For complete information on
NonTuberculous Mycobacteria Infection Market
Insights, Epidemiology Market Forecast-2028
please click the link below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

7
About DelveInsight
2
1
3

• DelveInsight 2019 All rights reserved

8
Services by DelveInsight
PharmDelve
Forecasting
Opportunity Assessment
Consulting
Report Store
Market Intelligence
Competitive Analysis
Pipeline

• DelveInsight 2019 All rights reserved

9
Contact Us
info_at_delveinsight.com
91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight

• DelveInsight 2019 All rights reserved

10
Pompe Disease
9